Indefinite Delivery Contract SPE2DX15D9334
- Not listed
- The federal contract IDV award SPE2DX15D9335 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, valid through November 2026, was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare...
- The federal contract IDV award SPE2DX15D9333 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities nationwide. The IDC covers an extensive portfolio of branded and...
- The federal contract IDV award SPE2DX15D9387 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,999,999.00 IDC was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program and is valid through December 31, 2025. Under this IDC, DMS Pharmaceutical Group Inc. provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical...
- The federal contract IDV award SPE2DX15D9380 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and held by the woman-owned small business DMS Pharmaceutical Group Inc. The contract was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program, with a period of performance from April 27, 2015 to December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the...
- This is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $4,999,999, covers a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide under the TRICARE West program. The task orders issued to date include firm...
- The federal contract IDV award SPE2DX15D9534 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) on September 9, 2015 and is valid through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to...
- The federal contract IDV award SPE2DX15D9159 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, with a ceiling value of $4,999,999.00 through December 2025. The contract enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The federal contract IDV award SPE2DX15D9983 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DX program and has a ceiling value of $4,999,999.00 with a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical...
- The federal contract IDV award SPE2DX15D9401 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program and has a ceiling value of $4,999,999.00, with a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical...
The federal contract IDV award SPE2DX15D9334 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) under the TRICARE West program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, including specialized pharmaceutical products such as Xolair, Trikafta, Keytruda, Botox, and Nucala. The contract enables the DLA to issue firm fixed-price delivery orders for these items, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain and providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract has an ultimate completion date of December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/27/15 |